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ABSTRACT
Summary: ArrayXPath (http://www.snubi.org/soft-
ware/ArrayXPath/) is a web-based service for map-
ping and visualizing microarray gene-expression
data with integrated biological pathway resources
using Scalable Vector Graphics (SVG). Deciphering
the crosstalk among pathways and integrating
biomedical ontologies and knowledge bases may
help biological interpretation of microarray data.
ArrayXPath is empowered by integrating gene-
pathway, disease-pathway, drug-pathway and
pathway–pathway correlations with integrated Gene
Ontology, Medical Subject Headings and OMIM
Morbid Map-based annotations. We applied Fisher’s
exact test and relative risk to evaluate the statistical
significanceofthecorrelations.ArrayXPathproduces
Javascript-enabledSVGsforweb-enabledinteractive
visualization of gene-expression profiles integrated
with gene-pathway-disease interactions enriched by
biomedical ontologies.
INTRODUCTION
Cluster analysis is one of the most powerful methods for the
exploratory analysis of gene-expression data. Gene-expression
clusters based on similarity measures between expression
proﬁles have positional associations along the chromosomes
(1,2), exhibit common cis-regulatory elements in their
upstream regions (3) and are coordinated by shared sets of
regulators (4). Gene-expression clusters can be assigned to the
well-known functional categories of the MIPS classiﬁcation
(5), the Gene Ontology (GO) terms (6) or pathway resources
(7) using annotations from public databases (3,8,9).
ArrayXPath (7) is a web-based application that (i) receives
a clustered gene-expression proﬁle of any microarray platform
in a tab-delimited text format; (ii) automatically resolves the
microarray probe identiﬁers (i.e. GenBank accession number,
UniGene ID, LocusLink ID, ofﬁcial gene symbol, SwissProt
ID or TrEMBL ID); (iii) searches major public pathway
resources (i.e. GenMAPP, KEGG, BioCarta and PharmGKB
Pathways); (iv) maps the different identiﬁer sets between
microarray probes and pathway nodes; (v) tests the statistical
signiﬁcance of the associations between gene-expression clus-
ters and pathways (hence providing an automated annotation
of clusters with the ranked pathways); (vi) visualizes expres-
sion levels onto pathways and (vii) allows web-based user
navigation through multiple clusters and pathways enriched
with animation features, using Javascript-enabled Scalable
Vector Graphics (SVG).
Although biological pathways can provide key information
about the organization of biological systems, relatively small
number (i.e. 3000) of genes compared with the estimated
number (i.e. >30000) of genes for our species, as reported by
our previous work (7), do appear in major pathway resources,
resulting in low coverage for genome-wide expression data
analysis. Although GO-based annotations give lesser informa-
tion than pathway-based ones, increasingly more gene pro-
ducts are being annotated by GO terms, resulting in much
higher coverage. As of February 2005, we found that 13949
LocusLink IDs have at least one GO annotations. Therefore,
integratinglesser-knowledge-higher-coverageGO-basedanno-
tations can complement more-knowledge-lower-coverage
pathway-based annotations for microarray data analysis.
Gene-pathway correlation alone may not be sufﬁcient for
deciphering the genomic secret of normal and pathological
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doi:10.1093/nar/gki450physiology. Integrating not only biological (i.e. GO) but also
clinical ontologies like the disease nomenclature system
supported by Medical Subject Headings (MeSH) can provide
further information for genotype-to-phenotype associations.
OMIM Morbid Map provides valuable gene-disease correla-
tions. Integrating drug-pathway correlations from PharmGKB
Pathways (10) can also improve ArrayXPath.
We found that pathways had signiﬁcant and informative
crosstalk. Many genes appear in multiple pathways. System-
atic analysis and interactive visualization of the complex
crosstalk structures among pathways, pathway nodes
(i.e. gene products) and gene-expression clusters may help
understanding gene-pathway correlations. Figure 1a shows
the concept diagram of new ArrayXPath that integrates the
quinta-partite graph structure of cluster, gene, disease, path-
way and GO-term associations from multiple resources.
Here we present an improved version of ArrayXPath. In
addition to the functionalities described above, this is a
software that (i) tests the statistical signiﬁcance of the
associations between gene-expression clusters and GO-
based annotations to complement pathway-based microarray
data analysis; (ii) allows users to search disease-related
pathways; (iii) visualizes the global crosstalk of biological
pathways by measuring and mapping the similarity distances
superimposed by the local crosstalk of the subset of pathways
matched to input gene-expression clusters and (iv) visualizes
the detailed local crosstalk through gene-cluster, gene-
pathway, gene-disease and gene-GO associations using
interactive multi-partite graph representations in SVG.
OMIM knowledge base and drug-pathway correlations
from PharmGKB Pathways are also tightly integrated to
ArrayXPath.
INPUT AND OUTPUT
Input
Input to ArrayXPath is a common tab-delimited text ﬁle for a
clustered gene expression proﬁle: <Probe ID>-<Cluster ID>-
[<Expression level at conditioni>]. The ﬁrst column must
contain either GenBank accession number, UniGene ID,
LocusLink ID, SwissProt ID, TrEMBL ID or an ofﬁcial
gene symbol. The second column contains the cluster ID.
The third to ith columns are optional and contain expression
levels. ArrayXPath does not perform cluster analysis per se.
The input format is designed primarily for a partitional
clustering algorithm (i.e. K-means or Self-Organizing
Maps) but a clustering result from a hierarchical algorithm
(i.e. dendrogram) may be applied by carefully choosing a
threshold. One can search disease-related pathways and
their correlations by entering a disease name.
Output
ArrayXPath produces a list of the best-matching pathways and
GO terms for each cluster with statistical signiﬁcance scores
of non-random association. Relevant pathways are listed in
ascending order of P-values (and multiple-comparison correc-
ted Q-values) (11). ArrayXPath provides a summary statistic
for the overall mapping between input clusters and all path-
ways and GO terms matched.
If one chooses a pathway among the list, ArrayXPath
outputs a Javascript-enabled SVG ﬁle, color-coded both by
expression level and by cluster membership at each pathway-
node level. If one chooses a cluster, ArrayXPath outputs
cluster-pathway-disease diagram with signiﬁcantly associated
GO terms and OMIM information (Figure 1c). The cluster-
centric view visualizes the related genes, pathways and dis-
eases by measuring the shared membership of gene products.
The whole quinta-partite associations (Figure 1a) can be inter-
actively navigated by choosing one of the cluster, pathway or
disease nodes from the graph in SVG.
Each node in the pathway graph and the correlation
multi-partite graph is enriched with a hyperlink to an auto-
mated summary page for the corresponding gene product(s)
provided by our integrated database: GRIP (Genome Research
Informatics Pipeline, http://grip.snubi.org/) (7).
METHODS
Pathway integration and resolving diverse identifiers
ArrayXPath searches publicly available major pathway
resources including KEGG, GenMAPP, BioCarta and
PharmGKB Pathways. We have created a repository of
meta-information by parsing SBML ﬁles for KEGG (http://
www.systems-biology.org/001/001.html) and HTML ﬁles
for GenMAPP (http://www.genmapp.org/HTML_MAPPs/
Human/MAPPIndex_Hs_Contributed.htm) and BioCarta
(http://www.biocarta.com/genes/allPathways.asp), and by
manually encoding PharmGKB pathways (http://www.
pharmgkb.org/search/pathway/pathway.jsp). A variety of
gene-product identiﬁers including GenBank accession num-
ber, UniGene ID, LocusLink ID, EC number, ofﬁcial gene
symbol, SwissProt ID and TrEMBL ID are inconsistently
used for the pathway nodes as well as microarray probes,
resulting in enormous ambiguity in integrating data from dif-
ferent resources. By integrating major databases including
GenBank, UniGene, LocusLink, Homologene, SwissProt,
Ensemble, UCSC Golden Path and NetAffyx (http://www.
affymetrix.com/analysis/index.affx), ArrayXPath automatic-
ally matches the probe identiﬁers of microarray data to the
identiﬁers of pathway nodes. When a pathway node is a com-
positetype,i.e.consistsofmorethanoneelement,ArrayXPath
separately matches and visualizes each probe identiﬁer to the
corresponding individual element of the composite object.
Table 1 shows the distribution of the pathway nodes
identiﬁed from KEGG, GenMAPP, BioCarta and PharmGKB
Pathways for Homo sapiens, Mus musculus and Rattus
norvegicus. We found 1942 redundant nodes representing
genes and proteins for the 45 GenMAPP pathways. Among
the 1454 non-redundant elements, ArrayXPath successfully
assigned 1391 gene products (95.7%) to either ofﬁcial gene
symbols (n = 1329; 91.4%), LocusLink ID (n = 39; 2.7%) or
SwissProt ID (n = 23; 1.6%). It is trivial to resolve LocusLink
ID once we obtain ofﬁcial gene symbol. The number 39 for
the LocusLink-ID column in Table 1 means that we could
resolve LocusLink IDs for the 1368 (= 1329 + 39) elements.
Similarly, there were far more than 23 elements having
SwissProt IDs. The number 23 for SwissProt-ID column
means that we could resolve SwissProt IDs for the 23 elements
for which we failed to resolve ofﬁcial gene symbol or
W622 Nucleic Acids Research, 2005, Vol. 33, Web Server issueLocusLink ID. Only 63 (4.3%) elements in GenMAPP remain
unresolved because of intractable ambiguity. KEGG has 256
non-composite (i.e. simple) and 121 composite elements (i.e.
enzymes), containing 256 and 505 gene products, respect-
ively. Among the 256 simple-type elements, 21 appear as
members of composite type elements. Overall, KEGG has
740 unique elements and ArrayXPath successfully assigned
all of them (100%) either to ofﬁcial gene symbol (n = 720,
97.3%) or LocusLink (n = 20, 2.7%). PharmGKB Pathways
added 133 ofﬁcial gene symbols and 1 LocusLink ID.
Overall, ArrayXPath identiﬁed 3151 gene products for the
four major pathways in our species. We created a pre-
computed association table of these elements to all resolvable
IDs and to ofﬁcial gene symbols for reliable mapping of
incoming microarray-probe identiﬁers.
Search pathways by disease name in MeSH
(PathMeSH)
ArrayXPath allows one to search disease-related pathways.
The OMIM Morbid Map (http://www.ncbi.nlm.nih.gov/
Omim/getmorbid.cgi) contains ofﬁcial gene symbol, alias
gene symbol and cytogenetic location of disease-related
genes with OMIM ID and the associated disease name. The
C category among the 15 branches of MeSH contains disease
names and their entry terms with hierarchical structure. We
extracted the gene-related and disease-related information
from OMIM and MeSH. We mapped the disease names by
using exact keyword match method provided by MeSH. We
mapped the disease-related genes onto the integrated pathway
resources by using our integrated database, GRIP, as described
above. Among the 3259 ofﬁcial gene symbols resolvable from
Pathway crosstalk
GO hierarchies
MeSH hierarchies
profile similarity
gene cluster
clustering
algorithms
LocusLink, MGD, etc.
ArrayXPath
OMIM Morbid Map
MeSH disease names
drug
OMIM knowledge base
PharmGKB
Pathways
gene product-centric summary
GRIP
GO
disease
pathway
(b)
(a)
Nucleic Acids Research, 2005, Vol. 33, Web Server issue W623the Morbid Map, we found that 2395 genes had disease names
that could be mapped to MeSH disease names through head-
ings or entry terms. We successfully mapped 1928 genes onto
both MeSH disease names and pathway nodes (i.e. gene pro-
ducts). It means that about 64% (i.e. 1928/3025) (Table 1) of
the non-redundant nodes in all pathway resources of our
species have at least one link to human pathophysiology
through standard disease name(s) in MeSH.
If the input disease name is matched to the corresponding
MeSH heading or entry term, ArrayXPath outputs the list of
the pathways containing the disease-related gene product
(Figure 1b). ArrayXPath determines the statistical signiﬁcance
AA923082
Cluster_11
AA424504
AAB63145
AA190747
W47666
AA251456
AB03245
AA504772
Coronary Disease
KEGG//Hs_Arginine_and_proline_metabolism
KEGG//Hs_Inositol_phosphate_metabolism
KEGG//Hs_One_carbon_pool_by_folate
KEGG//Hs_Glycoxylate_and_carboxylate_metabolism
KEGG//Hs_Folate_biosynthesis
KEGG//Hs_Glycin_serine_and_threonin_metabolism
KEGG//Hs_D-Arginine_and_D-ornitine_metabolism
KEGG//Hs_Spingoglycolipid_metabolism
KEGG//Hs_Nicotinate_and_nicotinamide_metabolism
GenMAPP//Hs_Apoptosis
Colon cancer and benign colon polyps (AMD1)
GenMAPP//Hs_MAPK_Cascade
GenMAPP//Hs_G13_Signaling_Pathway
AF07345
GenMAPP//Hs_Fatty_Acid_Synthesis
BioCarta//Hs_Integrin_Signaling_Pathway
(c)
Figure 1. ArrayXPath functions. (a) Gene-cluster, gene-pathway, gene-disease and gene-GO associations (solid lines) are the building blocks of the quinta-partite
graph representation used by ArrayXPath integration. Dotted lines explain how the associations are determined. GO and MeSH have their own hierarchical
organizations,clusterscanbeorganizedbyprofilesimilarity measures,andpathwaysbycrosstalks(brokencirculararrows).(b)PathMeSHreturnsalistofdisease-
relatedpathwayswithstatisticalsignificancescoresbyintegratingpathwayresources,MeSHdiseasenamesandOMIMMorbidMap.(c)Whenonechoosesacluster,
ArrayXPathoutputsthecluster-centricviewoftheassociationsofrelatedgenes,pathwaysanddiseasesthroughthesharedmembershipofgeneproducts.Thewhole
quinta-partiteassociationscanbeinteractivelynavigatedbychoosingcluster,pathwayordiseasenodefromthegraphinSVG.ArrayXPathalsoprovidesGO-based
annotation and OMIM information to complement pathway-based analysis of gene expression clusters.
Table 1. Distribution of pathway–node identifiers among the major pathway resources
Pathway Gene/protein ID resolution Metabolite Embedded Free text
Simple Complex Redundant Total OGS LL SP UR pathway description
H.sapiens
KEGG 70 (256)
a
(505)
a
740
(121) (469)
(637)
(1106)
740 720 20 0 0 1896 (2624) 0 (0) 121 (275)
GenMAPP 45 1454 (1942) 1391 1329 39 23 63 83 (97) 4 (4) 130 (372)
BioCarta 346 1584 (8976) 1584 1580 4 0 0 0 (0) 50 (141) 18 (53)
PharmGKB 9 134 (189) 134 133 1 0 0 11 (25) 1 (1) 23 (26)
Overall 470 3088 (12900) 3025 2938 64 23 63 1990 (2746) 55 (146) 55 (146)
M.musculus
BioCarta 277 1260 (7646) 1260 1224 36 0 0 1 (1) 37 (113) 75 (311)
R.norvegicus
KEGG 63 (160)
(277)
451
(72) (527)
(753)
(1280)
451 282 169 0 0 1774 (2435) 0 (0) 167 (72)
Numbers in parentheses are redundant counts. KEGG has 121 composite elements containing 505 identifiable gene products. OGS, official gene symbol;
LL, LocusLink; SP, SwissProt; and UR, unresolved.
aThere were 21 elements redundant in the simple (256) and composite (505) elements so that 740 unique elements were found in the 70 KEGG human pathways.
W624 Nucleic Acids Research, 2005, Vol. 33, Web Server issueof the association between a pathway and a disease name
in terms of the non-random proportion of matched entities.
ArrayXPath applies Fisher’s exact test by constructing a 2 · 2
contingency table containing the two pathway memberships
(within and without the pathway) as column variables and
the disease memberships (within and without the disease)
as row variables. We used Fisher’s exact test because a
large sample approximation is inappropriate in the pathway
case (a 2 · 2 table often contains a cell with expected
values <5).
(a)
(b)
Figure 2. Pathway crosstalk. (a) Calculating pairwise similarity matrix between each pair of pathways and applying multi-dimensional scaling method created the
global crosstalk graph of major biological pathways. Yellow nodes represent BioCarta, green nodes GenMAPP, red nodes KEGG and blue nodes PharmGKB
Pathways (see Methods). (b) ArrayXPath interactively visualizes the local crosstalk (i.e. sky-blue, light-green and purple lines) of the pathways associated with the
selected clusters (i.e. clusters 4, 7 and 9 respectively), superimposed on the global pathway crosstalk graph.
Nucleic Acids Research, 2005, Vol. 33, Web Server issue W625Visualization of the correlational structure of
biological pathways
Visualizing the crosstalk among pathways may reveal import-
ant biological understanding (12). We created a pairwise
similarity matrix of pathway distances by calculating the
ratio of the number of genes in the intersection to that in
the union of each pair of pathways. Multi-dimensional scaling
of the similarity matrix and drawing the edges of the pathway
pairs above certain similarity thresholds create a global cross-
talk graph among all biological pathways (Figure 2a). It is
demonstrated that metabolic pathways of KEGG (i.e. red
nodes) and signal transduction pathways of BioCarta (i.e.
yellow nodes) tend to form separate clusters.
ArrayXPath interactively visualizes the local crosstalk of
the pathways associated with the user-selected clusters, super-
imposed on the global pathway crosstalk graph (Figure 2b).
Figure 2b shows an interesting example where the pathways
mapped onto the selected three gene-expression clusters form
distinct clusters.
ArrayXPath interactively visualizes the detailed local
crosstalk. The shared membership of gene products in gene-
expression clusters, pathways and disease names can be cap-
tured by multi-partite graph representations in SVG (Figure 1a
and c). By selecting a node from one view, one can inter-
actively navigate the different views of the whole associations.
Mapping GO-based annotations
Among the 33108 LocusLink IDs (as of February 2005),
we identiﬁed 3025 gene products (i.e. 9%) in major path-
way resources (Table 1). Integrating GO-based annotations
covering 13949 LocusLink IDs (as of 2005 February) can
help ﬁlling the gaps for pathway-based microarray data
analysis. ArrayXPath provides both implicit and explicit
GO annotations (Figure 1c) (13). While explicit annotation
provides the GO terms directly mapped onto the members
of gene-expression clusters, implicit annotation considers
all ancestor terms from the GO hierarchical tree structure,
providing general understanding. We applied hypergeo-
metric distribution to evaluate the statistical signiﬁcance of
the associations.
DISCUSSION
ArrayXPath is a web-based service for mapping and visual-
izing microarray gene expression clusters with biomedical
ontologies and major biological pathway resources using
SVG. It permits one to input a clustered gene expression
data in a tab-delimited text format via an Internet connection.
We found that integrating biomedical ontologies including
GO-based annotations, disease names supported by MeSH,
and genotype-to-phenotype information from OMIM Morbid
Map greatly improve the capability of ArrayXPath to interpret
gene-expression proﬁles. Integrated analysis and interactive
visualization of the global and local crosstalks among path-
ways can facilitate system-level understanding of microarray
gene-expression data. Although we evaluated the statistical
signiﬁcance of each association in the present study, combined
analysis of the quinta-partite relationship may improve our
inference. Future studies are required to develop a computa-
tional method to reconstruct the whole correlational structure
and extract more biology from gene-expression microarray
data. Standard web-based integration of a wide range of bio-
informatics modules and heterogeneous genomic data will
obviously help advance biological science.
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